GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phoenix Life Sciences International Ltd (OTCPK:PLSI) » Definitions » Book Value per Share

Phoenix Life Sciences International (Phoenix Life Sciences International) Book Value per Share : $0.31 (As of Feb. 2019)


View and export this data going back to 2010. Start your Free Trial

What is Phoenix Life Sciences International Book Value per Share?

Phoenix Life Sciences International's book value per share for the quarter that ended in Feb. 2019 was $0.31.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

Phoenix Life Sciences International's current price is $0.0001. Its book value per share for the quarter that ended in Feb. 2019 was $0.31. Hence, today's PB Ratio of Phoenix Life Sciences International is 0.00.


Phoenix Life Sciences International Book Value per Share Historical Data

The historical data trend for Phoenix Life Sciences International's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phoenix Life Sciences International Book Value per Share Chart

Phoenix Life Sciences International Annual Data
Trend Feb11 Feb12 Feb13 Feb14 Feb15 Feb16 Feb17 Feb18 Feb19
Book Value per Share
Get a 7-Day Free Trial Premium Member Only -11.68 -43.11 -43.87 -39.95 0.31

Phoenix Life Sciences International Quarterly Data
May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -39.95 -28.78 -34.96 0.21 0.31

Competitive Comparison of Phoenix Life Sciences International's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Phoenix Life Sciences International's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phoenix Life Sciences International's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Phoenix Life Sciences International's PB Ratio distribution charts can be found below:

* The bar in red indicates where Phoenix Life Sciences International's PB Ratio falls into.



Phoenix Life Sciences International Book Value per Share Calculation

Phoenix Life Sciences International's Book Value Per Share for the fiscal year that ended in Feb. 2019 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(10.09-0.00)/32.58
=0.31

Phoenix Life Sciences International's Book Value Per Share for the quarter that ended in Feb. 2019 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(10.09-0.00)/32.58
=0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Phoenix Life Sciences International  (OTCPK:PLSI) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Phoenix Life Sciences International Book Value per Share Related Terms

Thank you for viewing the detailed overview of Phoenix Life Sciences International's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Phoenix Life Sciences International (Phoenix Life Sciences International) Business Description

Traded in Other Exchanges
N/A
Address
4262 Blue Diamond Road, Suite 102-277, Las Vegas, NV, USA, 89139
Phoenix Life Sciences International Ltd is an adaptive healthcare solutions company. Its business is to advance research and integrate programs and manufacturing of products that target and treat diabetes, pain, cancer, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. The company strive to create partnerships and integrate these programs for human health into communities worldwide as part of its Global Health Initiative. Its products include Onco, Metabolic, Transdermal Patche, Medi-Strip Relaxation, and others.

Phoenix Life Sciences International (Phoenix Life Sciences International) Headlines

From GuruFocus